Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;15(3):217–222. doi: 10.1111/j.1750-3639.2005.tb00523.x

Multiple Sclerosis Pathology: Evolution of Pathogenetic Concepts

Hans Lassmann 1
PMCID: PMC8095927  PMID: 16196388

Abstract

This historical review describes the evolution of pathogenetic concepts of multiple sclerosis (MS) from the viewpoint of pathology. MS research is based on studies of descriptive neuropathology, performed during the 19th and early‐20th century, which defined the basic nature of the inflammatory demyelinating lesions. Advances in basic immunology and neurobiology, performed during the second half of the 20th century, paved the way for the understanding of the molecular mechanims involved in inflammation and well as tissue destruction in this disease. However, recent clinical and neuroradiological studies on the evolution of the disease and its brain lesions as well as ongoing attempts to define the genetic basis of the disease indicate that our current pathogenetic concepts may be too simple and that essential aspects of MS pathology have to be redefined.

Full Text

The Full Text of this article is available as a PDF (432.7 KB).

References

  • 1. Anton G, Wohlwill F (1912) Multiple nicht eitrige Encephalomyelitis und multiple Sklerose. Z ges Neurol Psych 12:31–99. [Google Scholar]
  • 2. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schröder R, Deckert M, Schmidt S, Ravid R, Rajewsky K (2000) Clonal expansion of CD8+T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192:393–404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Babinski J (1885) Recherches sur l'anatomie pathologique de la sclerose en plaque et etude comparative des diverses varietes de la scleroses de la moelle. Arch Physiol (Paris) 5–6:186–207. [Google Scholar]
  • 4. Balo J (1928) Encephalitis periaxialis concentrica. Arch Neurol 19: 242–264. [Google Scholar]
  • 5. Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol 55:458–468. [DOI] [PubMed] [Google Scholar]
  • 6. Booss J, Esiri MM, Tourtellotte WW, Mason DY (1983) Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 62:219–232. [DOI] [PubMed] [Google Scholar]
  • 7. Brownell B, Hughes JT (1962) The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 25:315–320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Bunge MB, Bunge RP, Ris H (1961) Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord. J Biophys Biochem Cytol 10:67–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Cannella B, Raine CS (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 37:424–435. [DOI] [PubMed] [Google Scholar]
  • 10. Carswell R (1883) Pathological anatomy: illustrations on elementary forms of disease. Longman, London . [Google Scholar]
  • 11. Charcot JM (1880) Lecons sur les maladies du systeme nerveux faites a la Salpetriere . Tome 1, 4e ed. Paris.
  • 12. Charcot JM (1868) Histologie de la sclerose en plaque. Gaz Hopital (Paris) 41:554–566. [Google Scholar]
  • 13. Ciccarelli O, Werring DJ, Wheeler‐Kingshott CA, Barker GJ, Parker GJ, Thompson AJ, Miller DH (2001) Investigation of MS normal‐appearing brain using diffusion tensor MRI with clinical correlations. Neurology 56:926–933. [DOI] [PubMed] [Google Scholar]
  • 14. Compston A (2004) Genetic Susceptibility and Epidemiology. In: Lazzarini RA (Ed) Myelin Biology and Disorders Vol 2, Elsevier, Amsterdam pp 701–734. [Google Scholar]
  • 15. Cruveilhier J (18291842) Anatomie pathologique du corps humain . JB Bailliere, Paris.
  • 16. Cuzner ML, Opdenakker G (1999) Plasminogen activators and matrix metalloproteinases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J Neuroimmunol 94:1–14. [DOI] [PubMed] [Google Scholar]
  • 17. Devic E (1894) Myelite subaigue compliquee de nevrite optique. Bulletin Medical (Paris) 8:1033. [Google Scholar]
  • 18. Doinikow B (1915) Über De‐und Regenerationserscheinungen an Achsenzylindern bei der multiplen Sklerose. Z ges Neurol Psych 27:151–178. [Google Scholar]
  • 19. Esiri MM (1977) Immunoglobulin‐containing cells in multiple sclerosis plaques. Lancet 2:478–480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM (2000) Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 123:1845–1849. [DOI] [PubMed] [Google Scholar]
  • 21. Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120:393–399. [DOI] [PubMed] [Google Scholar]
  • 22. Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G (1998) Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 43:809–814. [DOI] [PubMed] [Google Scholar]
  • 23. Fog T (1950) Topographic distribution of plaques in the spinal cord in multiple sclerosis. Arch Neurol 63:382–414. [Google Scholar]
  • 24. Fraenkel M, Jakob A (1913) Zur Pathologie der multiplen Sklerose mit besonderer Berücksichtigung der akuten Formen. Z Neurol 14: 565–603. [Google Scholar]
  • 25. Fu L, Matthews PM, De‐Stefano N, Narayanan S, Francis GS, Antel JP, Wolfson C, Arnold DL (1998) Imaging axonal damage of normal‐appearing white matter in multiple sclerosis. Brain 121:103–113. [DOI] [PubMed] [Google Scholar]
  • 26. Ganter P, Prince C, Esiri MM (1999) Spinal cord axonal loss in multiple sclerosis: a post‐mortem study. Neuropathol Appl Neurobiol 25:459–467. [DOI] [PubMed] [Google Scholar]
  • 27. Gay FW, Drye GW, Dick GWA, Esiri MM (1997) The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis: Identification and characterization of the primary demyelinating lesion. Brain 120:1461–1483. [DOI] [PubMed] [Google Scholar]
  • 28. Gilden DH (2002) A search for virus in multiple sclerosis. Hybrid Hybridomics 21:93–97. [DOI] [PubMed] [Google Scholar]
  • 29. Golgi C (1872) Contribuzione alla fina anatomia degli organi centrali del sistema nervoso. Riv Clin 2:38–46. [Google Scholar]
  • 30. Huang D, Han Y, Rani MR, Glabinski A, Trebst C, Sorensen T, Tani M, Wang J, Chien P, O'Bryan S, Bielecki B, Zhou ZL, Majmuder S, Ransohoff RM (2000) Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev 177:52–67. [DOI] [PubMed] [Google Scholar]
  • 31. IFNB Multiple Sclerosis Study Group (1995) Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis. 1. Clinical results of a multicenter, randomized, double‐blind, placebo controlled trial. Neurology 43:655–661. [DOI] [PubMed] [Google Scholar]
  • 32. Ingle GT, Stevenson VL, Miller DH, Thompson AJ (2003) Primary progressive multiple sclerosis: a 5‐year clinical and MR study. Brain 126:2528–2536. [DOI] [PubMed] [Google Scholar]
  • 33. Jakob A (1915) Zur Pathologie der diffusen infiltrativen Encephalomyelitis in ihren Beziehungen zur diffusen und multiplen Sklerose. Z ges Neurol Psych 27:290–320. [Google Scholar]
  • 34. Kidd D, Thorpe JW, Kendall BE, Barker GJ, Miller DH, McDonald WI, Thompson AJ (1996) MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 60:15–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Kornek B, Lassmann H (1999) Axonal pathology in multiple sclerosis: a historical note. Brain Pathol 9: 651–656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Kornek B, Storch M, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive and remyelinated lesions. Am J Pathol 157:267–276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Lassmann H (1983) Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Springer Schriftenr Neurol 25:1–135. [PubMed] [Google Scholar]
  • 38. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717. [DOI] [PubMed] [Google Scholar]
  • 39. Luster AD (1998) Chemokines‐chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445. [DOI] [PubMed] [Google Scholar]
  • 40. Marburg O (1906) Die sogenannte “akute Multiple Sklerose Jahrbücher für Psychiatrie und Neurologie 27:211–312. [Google Scholar]
  • 41. Miller DH, Khan OA, Sheremata WA, Blum‐hardt LD, Rice GP, Libonati MA, Willmer Hulme AJ, Dalton CM, Miszkiel KA, O'Connor PW (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. New Engl J Med 348:15–23. [DOI] [PubMed] [Google Scholar]
  • 42. Müller E (1904) Pathologische Anatomie und Pathogenese. In: Die multiple Sklerose des Gehirns und Rückenmarks. Gustav Fischer, Jena , pp 300–344. [Google Scholar]
  • 43. Murray J (2004) Prelude to the framing of a disease: Multiple sclerosis in the period before Charcot's Lecons. Int MS J 11:78–85. [PubMed] [Google Scholar]
  • 44. Nyland H, Mork S, Matre R (1982) In situ characterization of mononuclear cell infiltrates in lesions of multiple sclerosis. Neuropathol Appl Neurobiol 8:403–411. [DOI] [PubMed] [Google Scholar]
  • 45. Prineas JW (1985) The neuropathology of multiple sclerosis. In: Handbook of Clinical Neurology (Koetsier J.C., ed.) Vol 47, pp 337–395, Elsevier, New York . [Google Scholar]
  • 46. Prineas JW, Barnard RO, Kwon E.E, Sharer LR, Cho ES (1993) Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 33: 137–151. [DOI] [PubMed] [Google Scholar]
  • 47. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES (1993) Multiple sclerosis. Pathology of recurrent lesions. Brain 116: 681–693. [DOI] [PubMed] [Google Scholar]
  • 48. Rindfleisch E (1863) Histologisches Detail zur grauen Degeneration von Gehirn und Rückenmark. Arch Pathol Anat Physiol Klin Med (Virchow) 26:474–483. [Google Scholar]
  • 49. Rivers TM, Sprunt DH, Berry GP (1933) Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 58:39–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Rovaris M, Bozzali M, Iannucci G, Ghezzi A, Caputo D, Montanari E, Bertolotto A, Bergamaschi R, Capra R, Mancardi GL, Martinelli V, Comi G, Filippi M (2002) Assessment of normal‐appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion‐tensor magnetic resonance imaging study. Arch Neurol 59:1406–1412. [DOI] [PubMed] [Google Scholar]
  • 51. Rovaris M, Bozzali M, Santuccio G, Caputo D, Montanari E, Bertolotto A, Bergamaschi R, Capra R, Mancardi GL, Martinelli V, Comi G, Filippi M (2001) In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 124:2540–2549. [DOI] [PubMed] [Google Scholar]
  • 52. Schlesinger H (1990) Zur Frage der akuten multiplen Sklerose und der encephalomyelitis disseminata im Kindesalter . Arb Neurol Inst (Wien) 17:410–432. [Google Scholar]
  • 53. Simmons ML, Frondoza CG, Coyle JT (1991) Immunocytochemical localization of N‐acetylaspartate with monoclonal antibodies. Neuroscience 45:37–45. [DOI] [PubMed] [Google Scholar]
  • 54. Steiner G (1931) Regionale Verteilung der Entmarkungsherde in ihrer Bedeutung für die Pathogenese der multiplen Sklerose. In: Krankheitserreger und Gewebsbefund bei multipler Sklerose. pp 108–120, Springer, Berlin . [Google Scholar]
  • 55. Sternberger LA, Hardy PH Jr, Cuculis JJ, Meyer HG (1970) The unlabeled antibody enzyme method of immunocytochenistry: preparation and properties of soluble antigen‐antibody complex (horseradish peroxidase‐antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 18:315–333. [DOI] [PubMed] [Google Scholar]
  • 56. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278–85. [DOI] [PubMed] [Google Scholar]
  • 57. Trapp BD (2004) Pathogenesis of multiple sclerosis: the eyes only see what the kind is prepared to comprehend. Ann Neurol 55:455–457. [DOI] [PubMed] [Google Scholar]
  • 58. Traugott U, Reinherz EL, Raine CS (1983) Multiple sclerosis: Distribution of T‐cell subsets within active chronic lesions. Science 219:308–310. [DOI] [PubMed] [Google Scholar]
  • 59. Valentiner GT (1856) Über die Sklerose des Gehirns und Rückenmarks. Deutsche Klin 147–151.
  • 60. Weigert C (1884) Ausführliche Beschreibung der in No. 2 dieser Zeitschrift erwähnten neuen Färbungsmethode für das Centralnervensystem. Fortschr Med 2:190–191. [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES